InsidersTradesSigma
Track the JW중외제약 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, JW중외제약 has recorded 37 insider filings. Market capitalisation: €521.9bn. The latest transaction was reported on 11 March 2026 (Other). Among the most active insiders: JW홀딩스. The full history is free.
37
Insider Decl.
n/a
Thresholds
n/a
19 ops.
Buy Volume
n/a
2 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 1,018 of 29,063 companies
81.1
score / 100
Value89
Quality73
FCF yld12%
Earn yld12%
EV/EBITDA5.1x
ROE20%
Gross mgn46%
Net mgn7.9%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 11 March 2026
Declarations37 total
25 of 37 declarations
关于 JW중외제약
JW Pharmaceutical 是一家韩国制药公司，专注于药物的开发和商业化。该公司在韩国交易所 XKRX 上市。